-The Hindu Business Line India should fine-tune its scheme to make it WTO-compliant The fact that the Centre’s new crop insurance scheme has hit a WTO speedbreaker does not really surprise. The EU, Canada, Australia and Thailand have implicitly said that in its present form, insurance payouts cannot readily be placed in the ‘green box’ — one that exempts certain expenditures from farm subsidy calculations for WTO purposes. They have, in effect,...

-The Telegraph New Delhi: One in five patients in India treated for heart attacks had to pay over a third of their annual household income from their pockets despite health insurance, according to a study that doctors say highlights poor health care protection. The study probing the financial impacts of serious acute coronary events in a sample of 1,635 patients from 41 hospitals across the country has also found that 60 per...

-The Hindu Several instances of in-kind transfers being successfully implemented. Social sector groups want Finance Minister to review the implementation of alternative subsidy systems before going ahead with Direct Benefit Transfer (DBT). “There have been several instances of in-kind transfers being successfully implemented in various parts of the country. Our appeal to the Finance Minister was to look at all the successful examples of alternative schemes before the government pushes ahead with the...

Representatives of around 20 civil society organizations and NGOs met the Finance Minister Shri Arun Jaitley as part of pre-budget consultation on social sector on 12 January, 2016. Immediately after the pre-budget consultation, a press conference was held by some of these organizations to convey the media persons what demands/ suggestions were made.   Subrat Das, Executive Director of Centre for Budget and Governance Accountability (CBGA, http://www.cbgaindia.org/) informed us that during...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...